Metabolic99.3% verified
Move cursor to rotate · 3D render
Metabolic · Compound
Tirzepatide
CAS
2023788-19-2
Dose
5mg per vial
Formula
C₂₂₅H₃₄₈N₄₈O₆₈
MW
4813.45 g/mol
Batch
PX-2026-0131
Purity
99.3%
Dual GLP-1 / GIP receptor agonist. Subject of extensive metabolic research.
Per vial · CAD
CAD $99
Selected
5mg per vial
Choose dose
Lyophilized · ambient-stable · In stock
Batch PX-2026-0131 →Research use only. Not for diagnostic, therapeutic, or human-consumption use.
Buying in volume? US and UK wholesale handled by direct contact — custom rates by monthly order volume.
Apply to the wholesale program Production COA
Per batch
Verification
3rd party
Form
Lyophilized
Current batch
The chromatogram for this vial.
Batch PX-2026-0131 · HPLC trace
Tirzepatide
Purity
99.3%
Produced
2026-02-28
Verified
2026-03-03
Signed by Independent third-party lab · 2026-03-03Hover the peaks to inspect retention times
Overview
About the compound.
Tirzepatide is a dual GIP and GLP-1 receptor agonist studied across the SURPASS clinical program in glycemic control and weight management research. Tested at production. Lyophilized, ambient-stable.
Research contexts
Dual-agonist metabolic researchIncretin pathway studies
Batch history
Every batch we’ve ever sent out.
Adjacent research
Compounds that pair with Tirzepatide.
Metabolic99.1% verified
CAS 2381089-83-2
C₂₁₄H₃₃₃N₅₀O₆₅
GLP-3 (Retatrutide)
5mg per vial · Batch PX-2026-0142
From CAD $129
per vial · CAD
Longevity99.0% verified
CAS 53-84-9
C₂₁H₂₇N₇O₁₄P₂
NAD+
500mg per vial · Batch PX-2026-0138
CAD $149
per vial · CAD
Recovery98.9% verified
CAS Blend
BPC-157 · TB-500 · GHK-Cu · KPV
KLOW
50mg blend per vial · Batch PX-2026-0133
CAD $219
per vial · CAD
5mg per vial
From CAD $99